Estrogen Receptor Polymorphisms: Significance to Human Physiology, Disease and Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3431|3|3|164-171

ISSN： 1872-2156

Source： Recent Patents on DNA & Gene Sequences, Vol.3, Iss.3, 2009-11, pp. : 164-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Significance of P2X7 Receptor Variants to Human Health and Disease

By  

Recent Patents on DNA & Gene Sequences, Vol. 5, Iss. 1, 2011-04 ,pp. : 41-54

Bentham Science Publishers

Access to resources Recommend Favorite

Current and Future Development of Estrogen Receptor Ligands: Applications in Estrogen-Related Cancers

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 210-229

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators. Current and Future Treatment Options for Osteoporosis

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 3, 2010-11 ,pp. : 206-218

Bentham Science Publishers

Access to resources Recommend Favorite

Polymorphisms in TOLL-Like Receptor Genes and their Roles in Allergic Asthma and Atopy

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 1, 2011-01 ,pp. : 45-56

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Drug Delivery of N-Acetylcarnosine (N-Acetyl-beta-alanyl-Lhistidine),Carcinine (Beta-alanylhistamine) and L-carnosine (Beta-alanyl-L-histidine) in Targeting Peptide Compounds as Pharmacological Chaperones for Use in Tissue Engineering, Human Disease Management and Therapy: From in vitro to the Clinic

By  

Recent Patents on Drug Delivery & Formulation, Vol. 4, Iss. 3, 2010-11 ,pp. : 198-230

Bentham Science Publishers

Access to resources Recommend Favorite